老年综合评估在老年血液系统肿瘤患者中的研究进展  

Progress of comprehensive geriatric assessment in elderly patients with hematologic malignancies

作　　者：高铭 白洁菲[2] 刘辉[2] Gao Ming;Bai Jiefei;Liu Hui(Graduate School,Peking University Health Science Center,Beijing 100191,China;Department of Hematology,Beijing Hospital,National Center of Gerontology,Beijing 100730,China)

机构地区：[1]北京大学医学部研究生院,100191 [2]北京医院国家老年医学中心血液科,100730

出　　处：《白血病．淋巴瘤》2018年第6期372-376,共5页Journal of Leukemia & Lymphoma

摘　　要：随着老年人血液系统肿瘤发病率的逐年升高,如何更好地评估老年血液肿瘤患者对化疗的耐受性是困扰临床医师的问题.最近老年综合评估开始用于老年血液肿瘤患者,研究发现老年综合评估可以判断患者预后,预测患者对治疗的耐受性,并有可能指导治疗决策.文章对国内外老年综合评估在血液肿瘤的研究现状进行综述.The incidence of hematologic malignancies in elderly is increasing year by year. So for clinicians, it is a problem to assess the tolerance to chemotherapy of elderly patients with hematological cancer. Recently, the comprehensive geriatric assessment has begun to be used in elderly patients with hematological malignancies. The studies have found that the comprehensive geriatric assessment could be used to assess the prognosis, predict the patient＇s tolerance to treatment, and may also be used as guidelines for making treatment decision. This paper mainly reviews the research status of comprehensive geriatric assessment in elderly patients with hematological malignancies at home and abroad.

关 键 词：血液系统肿瘤 老年综合评估 老年人 

分 类 号：R733[医药卫生—肿瘤]